Articles by Jen Jiang

Jennifer is a University of Western Ontario graduate with a degree in International Business. She strives to excel as a content creator in the digital sphere, working with clients in the Finance and Tech industry to leverage clickable taglines, images, and articles in driving traffic. When not writing, Jennifer enjoys photography, copywriting, and video production.

Energy

How Much of The Strategic Petroleum Reserve Oil Release Is Actually Ours?

Sep 5 Jen Jiang

In the wake of Hurricane Harvey, U.S. Energy Secretary Rick Perry authorized an emergency release of oil from the nation’s Strategic Petroleum Research on Thursday, in an effort to mitigate gasoline shortages. But how much ... [Read]

Computer Hardware

Hewlett Packard Raises Concern Over Micro Focus Spin-Off

Sep 1 Jen Jiang

Hewlett Packard Enterprise (NASDAQ:$HPE) saw a spin-off with Micro Focus International (LON:$MCRO), consequently raising concerns over reported inversion regulations. These regulations were set by the IRS (Internal Revenue Service) back in 2016. According to a ... [Read]

Energy

The Wrath of Hurricane Harvey on OPEC

Aug 31 Jen Jiang

While the sky clears over Houston, OPEC continues, and will for the foreseeable future, to suffer the persistent remaining damage of Hurricane Harvey. A point of reference? Harvey knocked over the largest refinery in the ... [Read]

Basic Materials

A Look At AK Steel’s Position In Today’s Coal Market

Aug 31 Jen Jiang

A fundamental competitive advantage of AK Steel (NASDAQ:$AKS) is its immunity to short-term fluctuations in coal prices. Why? The company purchases all of its coal under annual contracts. Similarly, U.S. Steel Corporation (NASDAQ:$X) purchases their ... [Read]

Biotechnology

ImmunoGen had an Impressive 12% Climb Today

Aug 30 Jen Jiang

The latest teaser in the biotechnology sector: Irish biotech company Jazz Pharmaceuticals (NASDAQ:$JAZZ) has signed a deal with ImmunoGen Inc. (NASDAQ:$IMGN) in the development of drugs in the Massachusetts-based company pipelines. This sent shares soaring ... [Read]

Biotechnology

The Market Empties On Otonomy Inc. Stock

Aug 30 Jen Jiang

Following truly abysmal results from a pivotal Phase 3 trial for its steroid candidate Otividex, Otonomy Inc. (NASDAQ:$OTIC) saw its investors parachuting out of their shares. The number? A cool 81.5% decrease. While about 600,000 ... [Read]

Consumer

Finish Line’s Shocking Shareholders Rights Plan

Aug 29 Jen Jiang

The athletic apparel and footwear sector have been performing abysmally lately. Finish Line (NASDAQ:$FINL) is no exception, ranking behind sport giants like Nike (NYSE: $NKE) and Foot Locker (NYSE: $FL). Recently, Finish Line shocked all ... [Read]

Consumer

Big 5 Sporting Goods Ex-Dividend Date Scheduled

Aug 29 Jen Jiang

August 30th, 2017 will be a huge day for Big 5 Sporting Goods Corporation (NASDAQ:$BGFV) as the company will begin trading ex-dividend. Accordingly, on September 15, 2017, a cash dividend payment of $0.15 per share ... [Read]